Results of various clinical trials testing different treatment options for colon cancer, including high-dose infusional 5-fluorouracil, encorafenib, binimetinib, cetuximab, and regular aspirin use, have shown promising outcomes in terms of survival and quality of life for patients with stage III or metastatic disease.